Sponsor content
868 result(s) found, displaying 311 to 320
-
Cancellation by sponsorRequested by Cipla Australia Pty Ltd
-
Prescription medicine registrationActive ingredients: Daptomycin.
-
Australian Public Assessment Report (AusPAR)AusPAR for Filpegla (pegfilgrastim) for the treatment of cancer patients following chemotherapy, to decrease the duration of severe neutropenia.
-
Australian Public Assessment Report (AusPAR)Ardalicip / Ciptunec (adalimumab) for the treatment of arthritis, crohn's disease, ulcerative colitis, psoriasis, uveitis and acne inversa.
-
Prescription medicine registrationActive ingredients: Methotrexate.
-
Australian Public Assessment Report (AusPAR)Trastucip and Tuzucip (trastuzumab) for the treatment of breast cancer and gastric cancer
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SEROFLO MULTIHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for FLUTICASONE SALMETEROL CIP HALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SEROFLO CIPHALER 250/50 fluticasone propionate/salmeterol 250/50 mcg/dose inhalation powder pre-dispensed BP plastic inhaler.
-
Prescription medicine registrationActive ingredients: Cinacalcet hydrochloride.